Janet M Maynard

FDA Approves First Treatment for Niemann-Pick Disease, Type C

• NPC is a serious disease that leads to enormous adverse impacts on patients and families. Despite extensive research efforts, there have not been approved treatments to meet the significant needs of patients, said Janet Maynard, M.D., M.H.S., director of the Office of Rare Diseases, Pediatrics, Ur
• Date: Sep 20, 2024
• Category: Business
• Source: Google